Genmab News

Genmab News

Date Title View
Apr 01, 2020
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
010420_CA16_Managerial Employees Transactions
Apr 01, 2020
Genmab A/S has published its Articles of Association
Articles of Association - March 31 2020 (UK)
Mar 31, 2020
Capital Increase in Genmab as a Result of Employee Warrant Exercise
200331_CA15_Warrant Exercise
Mar 30, 2020
Genmab A/S has published its Articles of Association
Articles of Association - March 26 2020 (UK)
Mar 30, 2020
Genmab Files Annual Report with the U.S. Securities and Exchange Commission
300320_i05_20F Filing
Mar 26, 2020
Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons
260320_CA14_Managerial Employee Transactions
Mar 26, 2020
Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to the New Member of the Board of Directors and a New Member of Management, and Grant of Restricted Stock Units and Warrants to Employees and a New Member
260320_CA13_Constitution of the Board and grant of RSUs and Warrants
Mar 26, 2020
Passing of Genmab A/S’ Annual General Meeting
260320_CA12_AGM Passing
Mar 12, 2020
Genmab A/S Provides Update to Annual General Meeting
200312_i04_AGM Update
Mar 10, 2020
Genmab Announces Appointment of Anthony Mancini to Newly Created Position of Chief Operating Officer
100320_CA11_COO
Feb 27, 2020
Notice to Convene the Annual General Meeting of Genmab A/S
200227_CA10_Genmab 2020 AGM Calling with Agenda and Appendices
Feb 26, 2020
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
260220_CA09_Man Empl Transaction (Sale of Shares)
Feb 26, 2020
Genmab A/S has published its Articles of Association
Articles of Association - February 25, 2020 (UK)
Feb 25, 2020
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
250220_CA08_Man Empl Transaction (Warrant Exercise)
Feb 25, 2020
Capital Increase in Genmab as a Result of Employee Warrant Exercise
250220_CA07_Warrant Exercise
Feb 24, 2020
U.S. FDA Filing Acceptance and Priority Review for sBLA, Submitted by Novartis, for Ofatumumab in Relapsing Multiple Sclerosis
240220_i03_Ofa SC Acceptances
Feb 21, 2020
Genmab Board of Directors Chairman to Step Down
210220_CA06_Board of Directors
Feb 19, 2020
Genmab Publishes 2019 Annual Report
05_Genmab_AR19_190220
Jan 23, 2020
Horizon Therapeutics Secures U.S. FDA Approval for Teprotumumab, for the Treatment of Thyroid Eye Disease (TED)
200123_i02_Teprotumumab US Approval
Jan 22, 2020
Genmab Announces 2019 Net Sales Figures for DARZALEX® (daratumumab) and Achievement of USD 150 Million Sales Milestone in DARZALEX Collaboration with Janssen
220120_CA04_DARZALEX FY 19 Sales_Milestone
Jan 20, 2020
Genmab Announces European Marketing Authorization for DARZALEX® (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma
200120_CA03_CASSIOPEIA EU Approval
Jan 06, 2020
Genmab to Present at the 38th Annual J.P. Morgan Healthcare Conference
200106_i01_JPM
Jan 02, 2020
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
200102_CA_02_Managerial Employees Transactions
Jan 02, 2020
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
200102_CA_01_Managerial Employee Transactions